Diuresis during spinal anesthesia MedDRA version: 9.1 Level: LLT Classification code 10041538 Term: Spinal anesthesia MedDRA version: 9.1 Level: LLT Classification code 10013523 Term: Diuresis
Conditions
Interventions
Trade Name: HemoHES 6%
Pharmaceutical Form:
Pharmaceutical form of the placebo: Intravenous infusion
Route of administration of the placebo: Intravenous use
Sponsors
Alysis Zorggroep
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients planned for short, minor surgery of lower extremity under spinal anesthesia. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: any urologic, neurologic, cardiac, vascular disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Determine effects of intravenous fluid preload (given just before spinal anesthesia) on volume of diuresis during spinal anesthesia induced detrusor blockade;Secondary Objective: Determine effects of intravenous fluid preload in preventing hypotension;Primary end point(s): 1) mean volume of diuresis during spinal anesthesia 2) number of subjects with diuresis volume over 500 ml | — |
Countries
Netherlands
Outcome results
None listed